https://newsletter.en.creamermedia.com
Africa|Health|Industrial|Manufacturing|SECURITY|Manufacturing
Africa|Health|Industrial|Manufacturing|SECURITY|Manufacturing
africa|health|industrial|manufacturing|security|manufacturing-industry-term

Nine finance institutions back Biovac’s expansion plans

Various vaccines

Photo by Reuters

1st March 2022

By: Marleny Arnoldi

Deputy Editor Online

     

Font size: - +

A consortium of nine development finance institutions (DFIs) has partnered with biopharmaceutical company Biovac, based in Cape Town, to support its vaccine manufacturing expansion plans.

Biovac aims to expand its vaccine manufacturing capacity in Africa initially through current activities related to the production of the Pfizer BioNTech Covid-19 vaccine for use exclusively in Africa.

To release increased local vaccine manufacturing capacity, Biovac needs to raise abound R2.3-billion, or $150-million.

The DFIs will support Biovac in this endeavour, as they too want increased local pharmaceutical manufacturing capability on the African continent.

The consortium is made up of the African Development Bank (AfDB); CDC Group – UK’s development finance institution which is soon to be renamed British International Investment; the German development finance institution DEG; the US International Development Finance Corporation; the European Investment Bank; the European Union Delegation to South Africa; the International Finance Corporation (IFC); the Industrial Development Corporation of South Africa; and the French development finance institution Proparco.

Biovac CFO Craig Mitchell says Covid-19 has proven that a more geographical spread of vaccine manufacturing is much needed globally, with the African continent having the lowest number of vaccine manufacturers. He believes the investment will not only enable Biovac to ramp up vaccine production for the current pandemic, but also build on capacity for routine vaccines and future pandemic vaccines as well.

IFC MD Makhtar Diop comments that the partnership between Biovac and the DFIs will boost production of a range of vaccines in Africa, which will build a more resilient health sector and strengthen regional value chains.

The AfDB says the partnership aligns with its 2030 Pharmaceutical Action Plan, which is aimed at increasing local production of pharmaceuticals to 70% by 2030 and of vaccines to 60% by 2040.

AfDB president Akinwumi Adesina says health security is fundamental to economic security. He highlights the importance of Africa becoming self-sufficient, as the continent cannot rely on global supply chains alone during times of crisis.

Edited by Chanel de Bruyn
Creamer Media Senior Deputy Editor Online

Comments

Showroom

Weir Minerals Africa and Middle East
Weir Minerals Africa and Middle East

Weir Minerals Europe, Middle East and Africa is a global supplier of excellent minerals solutions, including pumps, valves, hydrocyclones,...

VISIT SHOWROOM 
John Deere (Pty) Ltd
John Deere (Pty) Ltd

In 1958 John Deere Construction made its first introduction to the industry with their model 64 bulldozer.

VISIT SHOWROOM 

Latest Multimedia

sponsored by

Photo of Martin Creamer
On-The-Air (08/11/2024)
8th November 2024 By: Martin Creamer

Option 1 (equivalent of R125 a month):

Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format

Option 2 (equivalent of R375 a month):

All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.

Already a subscriber?

Forgotten your password?

MAGAZINE & ONLINE

SUBSCRIBE

RESEARCH CHANNEL AFRICA

SUBSCRIBE

CORPORATE PACKAGES

CLICK FOR A QUOTATION







sq:0.492 0.711s - 193pq - 2rq
Subscribe Now